<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 06 Dec 2009 08:45:05 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>The Deep, Inner Meaning Of Bank of America's (BAC) TARP Repayment</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</guid>
      <description><![CDATA[As expected, Bank of America (BAC) will repurchase its $45 billion TARP preferreds, funded in part by an additional $18.8 billion in &quot;common stock equivalents&quot;, $4.0 billion in asset sales, and $1.7 billion in restricted stock issued to employees in lieu of cash bonuses.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3688027>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 14:19:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WFC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</link>
    </item>
    <item>
      <title>Forget Yesterday, It's All About Jobs</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</guid>
      <description><![CDATA[Good morning. Stocks tanked in the last half-hour on Thursday and while the major news outlets attributed the decline to either profit taking or some trepidation in front of this morning's big Jobs report, we'd like to offer a little more substantial reason for the 85 point dive on an otherwise subdued day of trading.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3687896>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 13:21:30 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVLT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FSLR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPRO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRVL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NFLX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TXN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">V</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRSN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</link>
    </item>
    <item>
      <title>Fed Balance Sheet Declines By $15 Billion After Improbable Reduction In MBS, Excess Reserves, Monetary Base Hit Record</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</guid>
      <description><![CDATA[The Federal Reserve's balance sheet declined by $15 billion to $2,183 billion from the prior week, after the Fed presumably offloaded $2.7 billion in MBS: this is the first time since QE started that MBS holdings have declined. If anyone can tell us just who the idiots are who bought MBS from the Fed (and at what price), and who the even greater idiots are who are supposed to believe this, please send us an email.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3686922>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 04:14:41 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</link>
    </item>
    <item>
      <title>China Will Continue To Drive The Global Economic Recovery In 2010</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</guid>
      <description><![CDATA[China isn’t just leading the global economic recovery – it’s lapping the field.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683989>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 14:38:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GROW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</link>
    </item>
    <item>
      <title>Interesting Stat: How Much Private Sector GDP Is From Construction And Real Estate?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</guid>
      <description><![CDATA[Back in June, we discussed commercial real estate at length following attendance at a large real estate conference in NYC. Our tone was cautious and one question we wondered about was the percentage of GDP that real estate represents. We actually came across the answer back in August and meant to share then, but didn't get to it. Since the question/topic remains highly relevant to considering the potential negative economic drag from depressed real estate activity, we're sharing now -- the following table is from an 8/28/09 NYTs article, &quot;Construction That Fueled Growth in the Sun Belt Slows&quot;:<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683785>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 13:15:56 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</link>
    </item>
    <item>
      <title>Credit Market Overview:  Dec 3, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</guid>
      <description><![CDATA[The credit crunch crisis of confidence which we appear to be crawling out of even though the debt and equity markets catapulted themselves higher earlier this year could be similarly argued to be a crisis that started in the credit markets which crunched confidence around the world as it could a collapse in confidence in the value of the securities investors held which corrupted the credit markets causing them to cease funding.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683773>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 12:59:02 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</link>
    </item>
    <item>
      <title>Grab Some Northern Exposure With EWC</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</guid>
      <description><![CDATA[Emerging markets are captivating investors again, but tidy profits aren’t always far away. Placing your bets on well-established global markets can also prove rewarding. That's why we're looking at Canada.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3682040>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:39:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RIMM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</link>
    </item>
    <item>
      <title>Unemployment Struggling To Turn A Corner As Job Losses Mount In November</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</guid>
      <description><![CDATA[U.S. job losses in the private sector slowed in November but still exceeded economists’ projections, a report by payroll-processing firm Automatic Data Processing (Nasdaq: ADP) indicated yesterday (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681965>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:20:20 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</link>
    </item>
    <item>
      <title>Why Barrick Closed Their Gold Hedge</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</guid>
      <description><![CDATA[It sure looks like gold is going to close above $1,200 an ounce today in New York. And large open market purchases from central banks in China, India and Russia are only helping the price surge more. (Just one year ago, some of these same central banks were actually selling gold in an attempt to fill an annual 10,000-ton supply gap.)<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681409>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 19:15:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PAAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SSRI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</link>
    </item>
    <item>
      <title>How To Profit From The 'Next' Dubai</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3679796</guid>
      <description><![CDATA[The Dubai World default is a matter of only $60 billion – mere peanuts when compared to other elements of the global financial crisis. It’s thus of concern only to those silly enough to invest in real estate there (and the European banks foolish enough to finance it.) For the rest of us, it is a useful reminder that sudden collapses don’t really come out of nowhere – they can be foreseen, and smart investors can plan for them.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3679796>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 13:51:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3679796</link>
    </item>
    <item>
      <title>Vaccine maker expanding in city: Emergent BioSolutions to use East Lombard plant to produce more anthrax shots</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3636147</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 14--A Maryland maker of anthrax vaccine said Friday that it has bought a 55,000-square-foot manufacturing plant in East Baltimore that it will use to expand its operations, potentially creating as many as 125 jobs in the city over the next five years that initially were expected in Frederick. &lt;/li&gt;&lt;li&gt;Emergent BioSolutions Inc., a 600-person bio-pharmaceutical company with headquarters in Rockville, bought the East Baltimore facility for $7.85 million from the MdBio Foundation, a charitable and educational foundation that supports the state's bioscience industry. &lt;/li&gt;&lt;li&gt;Emergent spent $415,000 more to buy the land from the city.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3636147>[More...]</a>]]></description>
      <pubDate>Sat, 14 Nov 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3636147</link>
    </item>
    <item>
      <title>E. Baltimore plant purchased by anthrax vaccine maker: Expansion of Rockville-based company may mean as many as 125 jobs in city</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3635180</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 13--A Maryland maker of anthrax vaccine said Friday it bought a 55,000-square-foot manufacturing plant in East Baltimore that it will use to expand its operations, potentially creating as many as 125 jobs in the city over the next five years that initially were expected in Frederick. &lt;/li&gt;&lt;li&gt;Emergent spent another $415,000 to buy the land from the city of Baltimore. &lt;/li&gt;&lt;li&gt;The acquisition is part of a recent effort by Emergent to expand production capacity for its anthrax vaccine in Maryland and at a plant in Michigan, based on steady demand from the federal government.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3635180>[More...]</a>]]></description>
      <pubDate>Fri, 13 Nov 2009 21:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3635180</link>
    </item>
    <item>
      <title>EarthTalk: How Do 'Enertia Houses' Work?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3560825</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Dear EarthTalk: I recently saw a reference to &quot;Enertia houses&quot; that require little in the way of external sources for heating or cooling.  &lt;/li&gt;&lt;li&gt;Alan Marshfield, via e-mail&lt;/li&gt;&lt;li&gt;Enertia is a brand name for homes designed and sold in kits by North Carolina-based Enertia Building Systems (EBS).&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3560825>[More...]</a>]]></description>
      <pubDate>Mon, 19 Oct 2009 13:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LOGO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3560825</link>
    </item>
    <item>
      <title>Former Enron Executive Gets Prison Time for Hyping Firm</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3511106</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Sep. 28--Former Enron Broadband CEO Joe Hirko was sentenced this morning to 16 months in prison for his role in hyping the performance of the collapsed company's business through false press releases. &lt;/li&gt;&lt;li&gt;Enron Broadband Services was a business created by the former energy giant in the late 1990s to create a market for high speed data services, including video-on-demand. &lt;/li&gt;&lt;li&gt;Hirko and four others in the business unit were accused of pumping up the potential of EBS' data network to investors in early 2000 to enrich themselves by selling shares inflated by the hype.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3511106>[More...]</a>]]></description>
      <pubDate>Mon, 28 Sep 2009 20:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3511106</link>
    </item>
    <item>
      <title>Cubist Files Patent Infringement Lawsuit Against Teva Parenteral Medicines</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3143501</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Cubist Pharmaceuticals, a biopharmaceutical company, has filed a patent infringement lawsuit against Teva Parenteral Medicines, Teva Pharmaceuticals USA, and Teva Pharmaceutical Industries.&lt;/li&gt;&lt;li&gt;Cubist has filed the lawsuit in response to an abbreviated new drug application filed by Teva Parenteral Medicines seeking the FDA approval to market a generic version of daptomycin prior to the expiration of Cubist's patent rights. &lt;/li&gt;&lt;li&gt;Daptomycin is marketed in the US and internationally under the brand name Cubicin as therapy for serious skin and bloodstream infections caused by certain gram-positive bacteria.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3143501>[More...]</a>]]></description>
      <pubDate>Tue, 24 Mar 2009 16:57:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CBST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3143501</link>
    </item>
    <item>
      <title>Daily Record News Briefs: March 13, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3117748</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Baltimore Opera to liquidate &lt;/li&gt;&lt;li&gt;The Baltimore Opera Company said Thursday it was going to proceed with Chapter 7 bankruptcy, meaning the 58-year old nonprofit will liquidate all of its holdings to pay off creditors. &lt;/li&gt;&lt;li&gt;EntreMed Inc., of Rockville, a biopharmaceutical company, saw its net loss drop in the fourth quarter.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3117748>[More...]</a>]]></description>
      <pubDate>Fri, 13 Mar 2009 05:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMED</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ENMD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MED</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MITI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PIP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3117748</link>
    </item>
    <item>
      <title>'08 Contest Leaves Only 5 Entrants in the Black</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2946452</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Jan. 11--Garry Mills would like nothing more than for people to think him  a stock market wizard. &lt;/li&gt;&lt;li&gt;However, that pick -- Emergent BioSolutions Inc., a firm that makes  vaccines, including the only U.S.-approved vaccine for anthrax -- helped Mr.  Mills, 55, of Waterville, win The Blade's 2008 Stock Market Game. &lt;/li&gt;&lt;li&gt;In a disastrous year in which the Dow Jones industrial average lost $1.2  trillion, or 34 percent of its value, just five of last year's contestants  chose portfolios that finished above the $40,000 starting point.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2946452>[More...]</a>]]></description>
      <pubDate>Sun, 11 Jan 2009 19:18:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKNS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMKR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPRE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PANL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">POZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TSM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2946452</link>
    </item>
    <item>
      <title>'08 Blade Stock Contest Leaves Only 5 Entrants in the Black</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2946285</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Jan. 11--Garry Mills would like nothing more than for people to think him  a stock market wizard. &lt;/li&gt;&lt;li&gt;However, that pick -- Emergent BioSolutions Inc., a firm that makes  vaccines, including the only U.S.-approved vaccine for anthrax -- helped Mr.  Mills, 55, of Waterville, win The Blade's 2008 Stock Market Game. &lt;/li&gt;&lt;li&gt;In a disastrous year in which the Dow Jones industrial average lost $1.2  trillion, or 34 percent of its value, just five of last year's contestants  chose portfolios that finished above the $40,000 starting point.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2946285>[More...]</a>]]></description>
      <pubDate>Sun, 11 Jan 2009 18:15:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKNS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMKR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPRE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MHP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NWS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NYX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PANL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">POZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TSM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2946285</link>
    </item>
    <item>
      <title>Blockbuster Digital Media Debut Recalls Enron Venture</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2835111</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 26--Blockbuster's announcement Tuesday of the rollout of a digital media player to provide on-demand movies on home televisions may have generated a bit of deja vu for Enron junkies. &lt;/li&gt;&lt;li&gt;More than eight years ago, Blockbuster and pre-scandal Enron joined forces in a video-on-demand venture to deliver movies to homes via DSL. Dallas-based Blockbuster would obtain licenses from film studios to provide content, while Enron's fiber-optic network would stream movies to television set-top boxes. &lt;/li&gt;&lt;li&gt;On Tuesday, Blockbuster and 2Wire, a San Jose, Calif.-based broadband company, unveiled a compact digital media player that will allow customers access to thousands of Blockbuster movies with a broadband connection via built-in Wi-Fi or Ethernet cable.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2835111>[More...]</a>]]></description>
      <pubDate>Wed, 26 Nov 2008 15:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BBI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DVD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2835111</link>
    </item>
    <item>
      <title>Emirates Building Systems Accelerates Regional Expansion With Prestigious Kuwait Project</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2714005</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 16--Emirates Building Systems (EBS), a subsidiary of Dubai Investments Industries, the industry arm of Dubai Investments PJSC and a regional pioneer in the construction of high-rise steel buildings, has secured an AED 50 million contract for the construction of 'Kuwait World Trade Center', a prestigious business tower located in the heart of Kuwait City. &lt;/li&gt;&lt;li&gt;EBS has been aggressively building its presence in the Gulf region and beyond, and this new project in Kuwait further boosts our growth and consolidation strategy.&quot; &lt;/li&gt;&lt;li&gt;EBS has been steadily expanding its regional operations by successfully executing several high-profile projects in the GCC, including 'The Tower' on Sheikh Zayed Road in Dubai, and the 'Almoayyed Tower' and 'Trust Insurance Tower' projects in Bahrain.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2714005>[More...]</a>]]></description>
      <pubDate>Thu, 16 Oct 2008 19:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2714005</link>
    </item>
    <item>
      <title>Analyst Choice Updated Analysis on DENTSPLY International Inc., PAETEC Holding Corp., Antigenics Inc., Cubist Pharmaceuticals Inc., Alkermes Inc. and Biogen Idec Inc.</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3657587</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;All ten sectors ended in the red today led by technology, financial and energy sectors. &lt;/li&gt;&lt;li&gt;This drove us to do research on the following 6 stocks DENTSPLY International Inc. (NASDAQ: XRAY), PAETEC Holding Corp. (NASDAQ: PAET), Antigenics Inc. (NASDAQ: AGEN), Cubist Pharmaceuticals Inc. (NASDAQ: CBST), Alkermes Inc. (NASDAQ: ALKS) and Biogen Idec Inc. (NASDAQ: BIIB). &lt;/li&gt;&lt;li&gt;You can now access these research reports with many others by signing up at Analyst Choice.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3657587>[More...]</a>]]></description>
      <pubDate>Mon, 23 Nov 2009 11:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGEN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CBST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PAET</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XRAY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3657587</link>
    </item>
    <item>
      <title>Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3633270</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has   completed the acquisition of a 55,000 square foot manufacturing facility   from MdBio Foundation and the land on which the facility stands from the   City of Baltimore for a total purchase price of $8.2 million. &lt;/li&gt;&lt;li&gt;The   facility, located within the City of Baltimore, Maryland, previously   operated as a Food and Drug Administration (FDA) licensed facility used   by an experienced contract manufacturing organization (CMO) to produce a   number of FDA approved products.&lt;/li&gt;&lt;li&gt;&quot;Emergent is excited about this new facility in Baltimore because it   houses several suites capable of manufacturing multiple products at the   same time,&quot; said Fuad El-Hibri, chairman and chief executive officer of   Emergent BioSolutions.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3633270>[More...]</a>]]></description>
      <pubDate>Fri, 13 Nov 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3633270</link>
    </item>
    <item>
      <title>Dyax Corp. Announces Third Quarter 2009 Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3586339</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Dyax Corp. (NASDAQ: DYAX) today announced financial results for the   third quarter ended September 30, 2009. &lt;/li&gt;&lt;li&gt;Dyax will host a webcast and   conference call at 10 a.m. (ET) this morning to review the financial   results and corporate progress for the quarter.&lt;/li&gt;&lt;li&gt;Total revenues for the third quarter ended September 30, 2009 were $4.5   million, as compared to $5.5 million for the comparable quarter in 2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3586339>[More...]</a>]]></description>
      <pubDate>Wed, 28 Oct 2009 11:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CBST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DYAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3586339</link>
    </item>
    <item>
      <title>Cubist Pharmaceuticals 3rd Quarter Total Net Revenues Up 28%</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3555150</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for   the third quarter ended September 30, 2009.&lt;/li&gt;&lt;li&gt;With three quarters of 2009 revenue recorded, Cubist has tightened its   full year 2009 guidance for CUBICIN U.S. net revenue to between $520 and   $525 Million, which is within the range the company announced in   January. &lt;/li&gt;&lt;li&gt;Our strong top and bottom line results have   been achieved in an environment that has been tough for many branded   pharmaceuticals.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3555150>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 20:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALNY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CBST</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3555150</link>
    </item>
    <item>
      <title>Biotech Cools Off in August But Capital Markets Remain Positive</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3450057</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;SAN FRANCISCO, Sept. 1 /PRNewswire/ -- Just as biotech was &quot;hot&quot; in July it was a different story in August as the Burrill Biotech Select Index suffered from the summer &quot;blahs&quot; and posted a lackluster performance to close down 1.1 percent. &lt;/li&gt;&lt;li&gt;&quot;The final quarter of the year is traditionally one of biotech's best,&quot; said G. Steven Burrill, CEO, Burrill &amp; Company, a San Francisco based global leader in life sciences with activities in Private Equity, Venture Capital, Merchant Banking and Media, &quot;and we will likely see, despite the market uncertainties, the industry build on its momentum gained during the past several months.&lt;/li&gt;&lt;li&gt;The specialty pharmaceuticals company has products on the market, including a new injectable treatment for pain and fever, which is one of the reasons why the deal got done,&quot; noted Burrill.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3450057>[More...]</a>]]></description>
      <pubDate>Tue, 01 Sep 2009 18:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HGSI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ONXX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3450057</link>
    </item>
    <item>
      <title>Dyax Corp. Announces Expanded Roles for Two Senior Management Executives As Company Advances Commercialization Plan</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3449805</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet   medical needs, announced today that two senior executives will be taking   on expanded roles reflecting the Company's continued growth and plans   for commercialization. &lt;/li&gt;&lt;li&gt;Ivana Magov&amp;#196;&amp;#141;evi&amp;#196;&amp;#135;-Liebisch, appointed to the   position of Executive Vice President of Corporate Development and   General Counsel, will also oversee Business Development and Corporate   Compliance while continuing to supervise Corporate Communications,   Investor Relations and Legal. &lt;/li&gt;&lt;li&gt;In addition to directing the Company's   financial strategy and overseeing Accounting and Finance, George   Migausky, Executive Vice President and Chief Financial Officer, will   also oversee Information Technology and Human Resources.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3449805>[More...]</a>]]></description>
      <pubDate>Tue, 01 Sep 2009 16:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CBST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DYAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3449805</link>
    </item>
    <item>
      <title>Biotech Cools Off in August But Capital Markets Remain Positive</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3449808</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;SAN FRANCISCO, Sept. 1  /PRNewswire/ -- Just as biotech was &quot;hot&quot; in July it was a different story in August as the Burrill Biotech Select Index suffered from the summer &quot;blahs&quot; and posted a lackluster performance to close down 1.1 percent. &lt;/li&gt;&lt;li&gt;&quot;The final quarter of the year is traditionally one of biotech's best,&quot; said G. Steven Burrill, CEO, Burrill &amp; Company, a San Francisco based global leader in life sciences with activities in Private Equity, Venture Capital, Merchant Banking and Media, &quot;and we will likely see, despite the market uncertainties, the industry build on its momentum gained during the past several months.&lt;/li&gt;&lt;li&gt;The specialty pharmaceuticals company has products on the market, including a new injectable treatment for pain and fever, which is one of the reasons why the deal got done,&quot; noted Burrill.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3449808>[More...]</a>]]></description>
      <pubDate>Tue, 01 Sep 2009 16:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HGSI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ONXX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3449808</link>
    </item>
    <item>
      <title>Emergent BioSolutions Reports Financial Results for Second Quarter and First Six Months of 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3400179</guid>
      <description><![CDATA[Emergent BioSolutions Inc. (NYSE:EBS) announced today its financial results for the second quarter and six months ended June 30, 2009.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3400179>[More...]</a>]]></description>
      <pubDate>Thu, 06 Aug 2009 20:11:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3400179</link>
    </item>
    <item>
      <title>Emergent BioSolutions Expands Manufacturing and Development Infrastructure Through a Series of Real Estate Transactions</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3398780</guid>
      <description><![CDATA[Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into multiple real estate transactions that will expand the Company’s manufacturing and development infrastructure. These transactions should broaden the Company’s manufacturing options and increase the flexibility with which it uses its manufacturing assets, facilitate the continued growth of its product development programs, and reduce the Company’s overall debt and annual interest and operating expenses.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3398780>[More...]</a>]]></description>
      <pubDate>Thu, 06 Aug 2009 17:58:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3398780</link>
    </item>
    <item>
      <title>Almost Family Reports Second Quarter 2009 Results ; Recent Corporate Highlights:; - Net Service Revenues Increased 54% to $74.9 Million; - Visiting Nurse (VN) Segment Net Revenues Rose 65% to $64.0 Million; - Net Income Increased 54% to $6.0 Million; - Diluted EPS Increased 42% to $0.71 Per Share; - One-Time Acquisition Transaction Costs Lowered Diluted EPS By $0.02; - Expanded Presence in Central Florida With the Acquisition of Two Agencies</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3395062</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;LOUISVILLE, Ky., Aug. 5 /PRNewswire-FirstCall/ -- Almost Family, Inc. (Nasdaq: AFAM), a leading regional provider of home health nursing services, announced today its financial results for the three months ended June 30, 2009.&lt;/li&gt;&lt;li&gt;William Yarmuth, Chief Executive Officer, commented, &quot;We're pleased to report strong operating results for the second quarter. &lt;/li&gt;&lt;li&gt;Almost Family reported second quarter 2009 net service revenues of $74.9 million, a 54% increase from $48.7 million in the second quarter of 2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3395062>[More...]</a>]]></description>
      <pubDate>Wed, 05 Aug 2009 17:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AFAM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3395062</link>
    </item>
    <item>
      <title>Form  4          Emergent BioSolutions     For: Nov 25  Filed by: Intervac, L.L.C. (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3674329</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3674329>[More...]</a>]]></description>
      <pubDate>Mon, 30 Nov 2009 23:39:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3674329</link>
    </item>
    <item>
      <title>Form  4          Emergent BioSolutions     For: Nov 25  Filed by: El-Hibri Fuad (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3674328</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3674328>[More...]</a>]]></description>
      <pubDate>Mon, 30 Nov 2009 23:38:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3674328</link>
    </item>
    <item>
      <title>Form  4          Vetticaden Santosh        For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3520752</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3520752>[More...]</a>]]></description>
      <pubDate>Thu, 01 Oct 2009 19:36:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CBST</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3520752</link>
    </item>
    <item>
      <title>Form  4          Emergent BioSolutions     For: Sep 15  Filed by: Keese Kyle (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3509955</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3509955>[More...]</a>]]></description>
      <pubDate>Mon, 28 Sep 2009 16:00:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3509955</link>
    </item>
    <item>
      <title>Form  4          El-Hibri Fuad             For: Sep 23 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3507599</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3507599>[More...]</a>]]></description>
      <pubDate>Fri, 25 Sep 2009 23:32:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3507599</link>
    </item>
    <item>
      <title>Form  4          El-Hibri Fuad             For: Sep 17 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3495633</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3495633>[More...]</a>]]></description>
      <pubDate>Mon, 21 Sep 2009 23:11:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3495633</link>
    </item>
    <item>
      <title>Form  4          El-Hibri Fuad             For: Sep 14 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3486203</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3486203>[More...]</a>]]></description>
      <pubDate>Thu, 17 Sep 2009 00:20:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3486203</link>
    </item>
    <item>
      <title>Form  4          Bailey Sue                For: Sep 11 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3482501</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3482501>[More...]</a>]]></description>
      <pubDate>Tue, 15 Sep 2009 21:02:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3482501</link>
    </item>
    <item>
      <title>Form  4          El-Hibri Fuad             For: Sep 10 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3479321</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3479321>[More...]</a>]]></description>
      <pubDate>Mon, 14 Sep 2009 22:57:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3479321</link>
    </item>
    <item>
      <title>Form  4          Altman Henry M JR         For: Sep 04 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3460431</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3460431>[More...]</a>]]></description>
      <pubDate>Fri, 04 Sep 2009 21:33:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AFAM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3460431</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=AFAM,CBST,EBS," rel="self" type="application/rss+xml" />
  </channel>
</rss>